...
首页> 外文期刊>BMC Cancer >Comprehensive analyses of imprinted differentially methylated regions reveal epigenetic and genetic characteristics in hepatoblastoma
【24h】

Comprehensive analyses of imprinted differentially methylated regions reveal epigenetic and genetic characteristics in hepatoblastoma

机译:印迹差异甲基化区域的综合分析揭示了肝母细胞瘤的表观遗传和遗传特征

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background Aberrant methylation at imprinted differentially methylated regions (DMRs) in human 11p15.5 has been reported in many tumors including hepatoblastoma. However, the methylation status of imprinted DMRs in imprinted loci scattered through the human genome has not been analyzed yet in any tumors. Methods The methylation statuses of 33 imprinted DMRs were analyzed in 12 hepatoblastomas and adjacent normal liver tissue by MALDI-TOF MS and pyrosequencing. Uniparental disomy (UPD) and copy number abnormalities were investigated with DNA polymorphisms. Results Among 33 DMRs analyzed, 18 showed aberrant methylation in at least 1 tumor. There was large deviation in the incidence of aberrant methylation among the DMRs. Kv DMR1 and IGF2 -DMR0 were the most frequently hypomethylated DMRs. INPP5Fv2 -DMR and RB1 -DMR were hypermethylated with high frequencies. Hypomethylation was observed at certain DMRs not only in tumors but also in a small number of adjacent histologically normal liver tissue, whereas hypermethylation was observed only in tumor samples. The methylation levels of long interspersed nuclear element-1 (LINE-1) did not show large differences between tumor tissue and normal liver controls. Chromosomal abnormalities were also found in some tumors. 11p15.5 and 20q13.3 loci showed the frequent occurrence of both genetic and epigenetic alterations. Conclusions Our analyses revealed tumor-specific aberrant hypermethylation at some imprinted DMRs in 12 hepatoblastomas with additional suggestion for the possibility of hypomethylation prior to tumor development. Some loci showed both genetic and epigenetic alterations with high frequencies. These findings will aid in understanding the development of hepatoblastoma.
机译:背景技术已在包括肝母细胞瘤在内的许多肿瘤中报道了人11p15.5的印迹差异甲基化区域(DMR)的异常甲基化。然而,尚未在任何肿瘤中分析分散在人类基因组中的印迹位点中印迹DMR的甲基化状态。方法采用MALDI-TOF MS和焦磷酸测序技术,分析12例肝母细胞瘤和邻近正常肝组织中33种印记DMR的甲基化状态。用DNA多态性研究单亲二体性(UPD)和拷贝数异常。结果在分析的33个DMR中,有18个在至少1个肿瘤中显示出异常的甲基化。 DMR之间异常甲基化的发生率存在较大偏差。 Kv DMR1和IGF2-DMR0是最常见的次甲基化DMR。 INPP5Fv2-DMR和RB1-DMR被高甲基化。在某些DMR中不仅在肿瘤中而且在少数相邻的组织学正常的肝组织中均观察到了低甲基化,而仅在肿瘤样品中观察到了高甲基化。长时间散布的核元素1(LINE-1)的甲基化水平在肿瘤组织和正常肝脏对照之间没有显示出较大差异。在某些肿瘤中也发现了染色体异常。 11p15.5和20q13.3位点显示了遗传和表观遗传变化的频繁发生。结论我们的分析揭示了12例肝母细胞瘤中某些印迹DMR处的肿瘤特异性异常甲基化,并进一步暗示了肿瘤发展之前可能发生甲基化不足的可能性。一些基因座显示出高频率的遗传和表观遗传改变。这些发现将有助于了解肝母细胞瘤的发展。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号